Mesoblast reported 86.46M in Current Assets for its fiscal semester ending in June of 2024.


Current Assets Change Date
Avita Medical AUD 57M 15.96M Dec/2024
Clinuvel Pharmaceuticals AUD 222.06M 20.56M Jun/2024
Cochlear AUD 1.41B 41.5M Dec/2024
CSL USD 11.31B 540M Dec/2024
Pacific Edge NZD 30.82M 13.49M Mar/2025
Paradigm Biopharmaceuticals AUD 32.29M 8.04M Dec/2024
PYC Therapeutics AUD 62.12M 23.49M Dec/2024
Ramsay Health Care AUD 3.41B 465.3M Dec/2024
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Starpharma Holdings AUD 26.25M 6.67M Dec/2024
Telix Pharmaceuticals AUD 918.56M 663.3M Dec/2024